Gilead Sciences (GILD) Profit After Tax (2009 - 2026)
Gilead Sciences posted quarterly Profit After Tax of $2.0 billion for Q1 2026, up 53.69% year-on-year from $1.3 billion in Q1 2025, and down 7.42% on a QoQ basis from $2.2 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Profit After Tax data on file, last reported at $2.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 53.69% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $9.2 billion (up 54.5% YoY), and the FY2025 full-year result was $8.5 billion, up 1672.92% from the prior year.
- Profit After Tax for Q1 2026 stood at $2.0 billion, down from $2.2 billion in the prior quarter.
- Across five years, Profit After Tax topped out at $3.1 billion in Q3 2025 and bottomed at -$4.2 billion in Q1 2024.
- The 5-year median for Profit After Tax is $1.6 billion (2022), against an average of $1.2 billion.
- The widest annual swing landed in 2023, when Profit After Tax jumped 5215.79%; it then tumbled 512.87% in 2024.
- A 5-year view of Profit After Tax shows it stood at $1.6 billion in 2022, then dropped by 14.68% to $1.4 billion in 2023, then rose by 29.48% to $1.8 billion in 2024, then rose by 22.43% to $2.2 billion in 2025, then dropped by 7.42% to $2.0 billion in 2026.
- The last three Profit After Tax figures came in at $2.0 billion (Q1 2026), $2.2 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 7.40 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 5.24 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 697.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -4.24 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.71 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.68 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 2.18 Bn |
| Sep 30, 2025 | 3.05 Bn |
| Jun 30, 2025 | 1.96 Bn |
| Mar 31, 2025 | 1.32 Bn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | -4.17 Bn |
| Dec 31, 2023 | 1.38 Bn |
| Sep 30, 2023 | 2.17 Bn |
| Jun 30, 2023 | 1.05 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.61 Bn |
| Sep 30, 2022 | 1.79 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 19.00 Mn |
| Dec 31, 2021 | 358.00 Mn |
| Sep 30, 2021 | 2.59 Bn |
| Jun 30, 2021 | 1.52 Bn |
| Mar 31, 2021 | 1.72 Bn |
| Dec 31, 2020 | 1.55 Bn |
| Sep 30, 2020 | 353.00 Mn |
| Jun 30, 2020 | -3.34 Bn |
| Mar 31, 2020 | 1.54 Bn |
| Dec 31, 2019 | 2.69 Bn |
| Sep 30, 2019 | -1.17 Bn |
| Jun 30, 2019 | 1.88 Bn |
| Mar 31, 2019 | 1.98 Bn |
| Dec 31, 2018 | 3.00 Mn |
| Sep 30, 2018 | 2.10 Bn |
| Jun 30, 2018 | 1.82 Bn |
| Mar 31, 2018 | 1.54 Bn |
| Dec 31, 2017 | -3.84 Bn |
| Sep 30, 2017 | 2.71 Bn |
| Jun 30, 2017 | 3.07 Bn |
| Mar 31, 2017 | 2.70 Bn |
| Dec 31, 2016 | 3.11 Bn |
| Sep 30, 2016 | 3.33 Bn |
| Jun 30, 2016 | 3.50 Bn |
| Mar 31, 2016 | 3.57 Bn |
| Dec 31, 2015 | 4.69 Bn |
| Sep 30, 2015 | 4.60 Bn |
| Jun 30, 2015 | 4.50 Bn |
| Mar 31, 2015 | 4.33 Bn |
| Dec 31, 2014 | 3.46 Bn |
| Sep 30, 2014 | 2.73 Bn |
| Jun 30, 2014 | 3.66 Bn |
| Mar 31, 2014 | 2.23 Bn |
| Dec 31, 2013 | 787.00 Mn |
| Sep 30, 2013 | 784.00 Mn |
| Jun 30, 2013 | 773.00 Mn |
| Mar 31, 2013 | 722.00 Mn |
| Dec 31, 2012 | 758.96 Mn |
| Sep 30, 2012 | 671.04 Mn |
| Jun 30, 2012 | 711.56 Mn |
| Mar 31, 2012 | 437.53 Mn |
| Dec 31, 2011 | 661.76 Mn |
| Sep 30, 2011 | 441.96 Mn |
| Jun 30, 2011 | 742.46 Mn |
| Mar 31, 2011 | 651.14 Mn |
| Dec 31, 2010 | 629.42 Mn |
| Sep 30, 2010 | 704.88 Mn |
| Jun 30, 2010 | 712.06 Mn |
| Mar 31, 2010 | 854.90 Mn |
| Dec 31, 2009 | 799.39 Mn |
| Sep 30, 2009 | 673.03 Mn |
| Jun 30, 2009 | 571.40 Mn |
| Mar 31, 2009 | 586.58 Mn |